Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)

The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.

Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched

A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.

CEPI and University of Oxford to accelerate vaccine development against Disease X

The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.

New partnership to enhance global surveillance of pandemic threats

PSI and the WHO Hub for Pandemic and Epidemic Intelligence will collaborate to improve the detection and tracking of infectious diseases.

Preparing for the next pandemic together

PSI Director Professor Sir Peter Horby explains how relationships across scientific disciplines, sectors and global regions are key to preventing and preparing for future pandemics.

PSI hosts Oxford conference to prepare for future of pandemics

Representatives from academia, industry, policy and civil society are gathering in Oxford next week to discuss the latest scientific advances that are ensuring the world is better prepared for future pandemics.

PSI Director tells MPs why investment in pandemic research is critical

PSI Director Professor Sir Peter Horby today gave evidence at the House of Commons’ Science, Innovation and Technology Select Committee Inquiry on Emerging Diseases and Learnings from COVID-19.

Professor Sir Andrew Pollard reveals unique insights into the world of science in a new podcast

Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.

Call for abstracts: International Pandemic Sciences Conference

Abstract submission for the International Pandemic Sciences Conference 2023 - Making the Exceptional Routine has been extended to Friday 28 April 2023.

£12 million investment for Future Vaccines Manufacturing Hub

A new Future Vaccines Manufacturing Hub – co-led by University of Oxford and University College London – aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.

Sarah Gilbert receives King Faisal Prize for Medicine

Professor Dame Sarah Gilbert has been awarded the prestigious King Faisal Prize in recognition of her work to co-create a COVID-19 vaccine that has saved an estimated six million lives.

NHS COVID-19 app saved estimated 10,000 lives in its first year, new research finds

A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.

PSI partners with Royal Veterinary College to bolster research into infectious disease

The Pandemic Sciences Institute announces a new partnership with the Royal Veterinary College to facilitate collaborative research into infectious diseases.

Why diversity matters in vaccine science

Professor Teresa Lambe sets out her advice for young scientists to mark the International Day of Women and Girls in Science.

Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award

A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.

Sarah Gilbert awarded 2023 King Faisal Prize

Professor Dame Sarah Gilbert, the Saïd Chair of Vaccinology in the Nuffield Department of Medicine has been selected to receive King Faisal Prize for Medicine for 2023, along with Professor Dan Barouch of Harvard Medical School.

Exclusive interview with Professor Miles Carroll

Here at VaccineNation we are delighted to kickstart the new year with another one of our recorded interviews from the World Vaccine Congress in Europe. As we look forward to the Congress in Washington in April, we will be releasing further interviews and exploring key themes for the event. For this interview we were lucky to secure a slot with Professor Miles Carroll of Oxford University. A specialist in high consequence emerging viral infections, his insight into how we respond to new threats and prepare for the future is incredibly exciting!

Meet the man preparing Britain for the next pandemic

Despite facing a funding shortfall, Sir Professor Peter Horby is hard at work devising a defence blueprint for the next outbreak

Research at the Outbreak of a Pandemic – thanking our donors

During the first lockdown in early 2020, an emergency Coronavirus Research Fund was set up to channel the huge amounts of gifts that started pouring in, and to direct them quickly to the research projects that had the biggest chance of mitigating the worst effects of the pandemic.

Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists

The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.

Load More